CMCO · Columbus McKinnon Corporation

Current Thesis

Columbus McKinnon's acquisition-led deleveraging story now requires a price recovery: this refresh tests whether a daily close above the former $18.50 shelf occurs before a new daily close below the August 21 reference close of $17.62. The original breakout thesis already failed; the September 11, 2026 adjusted close of $17.74 remains below its published $18.50 invalidation level. This is a separate, prospective recovery test, not an extension of the failed forecast.

The underlying operating evidence remains the July 30, 2026 guidance increase following the first full quarter with Kito Crosby. The narrative is maturing — Zacks revisited analyst-target upside on August 10 and August 26, while the September 11 close still sits below the July reaction shelf. That classification is an inference about the story's development; a recovery above $18.50 accompanied by a subsequent guidance increase would challenge it. Zacks, August 10, Zacks, August 26

Bullish and bearish views on Columbus McKinnon Corporation

The model's bull view on Columbus McKinnon Corporation (CMCO), in brief: Orders exceeded quarterly revenue. For the quarter ended June 30, 2026, Columbus McKinnon reported $568.1 million of orders and a 1.1x ratio of orders to sales; legacy-business sales increased 12.7% year over year. These are operating observations, not proof of sustained… The bear view: The published structure already failed. The August 21, 2026 close of $17.62 breached the former $18.50 shelf, as documented in the August 30 public dossier. The September 11 adjusted close of $17.74 has not recovered that shelf. Debt reduction remains unproven. At June 30, 2026… Both cases follow in full.

Bull Case

• Orders exceeded quarterly revenue. For the quarter ended June 30, 2026, Columbus McKinnon reported $568.1 million of orders and a 1.1x ratio of orders to sales; legacy-business sales increased 12.7% year over year. These are operating observations, not proof of sustained deleveraging. July 30 earnings release
• Management raised the annual outlook. On July 30, 2026, the company raised fiscal 2027 sales guidance to $2.09–2.15 billion and adjusted earnings per share guidance to $1.90–2.10. A subsequent reduction would undermine the operating case behind a price recovery. July 30 earnings release

Bear Case

• The published structure already failed. The August 21, 2026 close of $17.62 breached the former $18.50 shelf, as documented in the August 30 public dossier. The September 11 adjusted close of $17.74 has not recovered that shelf.
• Debt reduction remains unproven. At June 30, 2026, the Credit Agreement Net Leverage Ratio was 4.9x, while quarterly free cash flow was $20.0 million. One combined quarter is too small a sample to establish a durable deleveraging trend. July 30 earnings release

Setup & Price Structure

The September 11, 2026 adjusted market data show a $17.74 close, a three-month price increase of 28.7%, and a price 22.9% below the $23.01 trailing annual high. The 14-day relative strength index (RSI) reads 51.0. These measurements show that a positive three-month change coexists with a failed breakout; they do not establish accumulation.

The $17.62 marker is the dated August 21 close, not a demonstrated support base. For observations after September 11, the recovery case resolves positively on a daily close above $18.50 before another daily close below $17.62. The earlier breach of $18.50 remains recorded as a failure.

Retail-facing coverage repeated the analyst-target argument on August 10 and August 26, 2026. Those articles document attention, but the sample is too small to support a crowding claim. Current short-interest, fund-flow and moving-average measurements are missing; the September 11 RSI cannot substitute for them. Zacks, August 26

Catalyst Calendar (next 30 days)

• ~2026-10-29, estimated — Fiscal second-quarter results. This later event is the operating test of the raised outlook and June-quarter leverage. Barchart lists October 29; the date remains unconfirmed by a company announcement in the available evidence. Barchart earnings calendar

Elapsed catalysts

• 2026-09-16 — Federal Reserve policy decision. The Federal Open Market Committee concludes its scheduled meeting that day. This is a macroeconomic event, not a company earnings catalyst; Columbus McKinnon's July 30 fiscal 2027 outlook assumes $185–190 million of interest expense. Federal Reserve calendar, company outlook (passed 4d ago)

What Would Change Our Mind

Failure to retain the August reference close would end the prospective recovery case: a daily close below $17.62 after September 11, 2026 invalidates it before the $18.50 recovery condition is reached. Neither level establishes that acquisition integration has succeeded.

The next reported Credit Agreement Net Leverage Ratio above June 30's 4.9x, or a reduction to the July 30 sales outlook, would separately weaken the operating thesis. A lower reported ratio with the outlook maintained would improve the evidence for deleveraging, without reversing the historical breakout failure.

Correlation Notes

This remains a single-company integration case. The July 30, 2026 release attributes legacy-business growth to pricing and volume, while acquisition integration underpins the revised outlook. No paired return series establishes a measured relationship with semiconductor equipment or an artificial-intelligence investment theme; those associations are unsupported here. July 30 earnings release

The September 16 Federal Reserve decision supplies a dated macroeconomic reference, but no measured interest-rate sensitivity is available. A company revision to its interest-expense outlook would be stronger evidence of financing pressure than a coincident share-price move.